right-img
Home Featured News Finance News Banking News
finaceandbankingnewsnow
Home | Weekly Analysts’ Ratings Changes for Clovis Oncology (CLVS)

Weekly Analysts’ Ratings Changes for Clovis Oncology (CLVS)

  • May 20, 2015
  • Clovis Oncology (NASDAQ: CLVS) has recently received a number of price target changes and ratings updates: 5/18/2015 – Clovis Oncology had its price target raised by analysts at Stifel Nicolaus to $125.00. 5/16/2015 – Clovis Oncology had its “buy” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $125.00 price target on the […]This article (Weekly Analysts’ Ratings Changes for Clovis Oncology (CLVS)) was originally developed by and is property of American Banking News. Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

  • Read more at:http://www.americanbankingnews.com/2015/05/20/weekly-analysts-ratings-changes-for-clovis-oncology-clvs/
  • Other News
Site Created by finaceandbankingnewsnow.com